Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.21
IMRS's Cash to Debt is ranked lower than
84% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.42 vs. IMRS: 0.21 )
Ranked among companies with meaningful Cash to Debt only.
IMRS' s 10-Year Cash to Debt Range
Min: 0.21   Max: No Debt
Current: 0.21

Equity to Asset 0.18
IMRS's Equity to Asset is ranked lower than
90% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. IMRS: 0.18 )
Ranked among companies with meaningful Equity to Asset only.
IMRS' s 10-Year Equity to Asset Range
Min: 0.18   Max: 0.81
Current: 0.18

0.18
0.81
F-Score: 3
Z-Score: -4.03
M-Score: -3.99
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -79.39
IMRS's Operating margin (%) is ranked lower than
87% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.85 vs. IMRS: -79.39 )
Ranked among companies with meaningful Operating margin (%) only.
IMRS' s 10-Year Operating margin (%) Range
Min: -180.07   Max: -1.4
Current: -79.39

-180.07
-1.4
Net-margin (%) -104.54
IMRS's Net-margin (%) is ranked lower than
90% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.03 vs. IMRS: -104.54 )
Ranked among companies with meaningful Net-margin (%) only.
IMRS' s 10-Year Net-margin (%) Range
Min: -184.84   Max: -2.51
Current: -104.54

-184.84
-2.51
ROE (%) -139.54
IMRS's ROE (%) is ranked lower than
95% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.27 vs. IMRS: -139.54 )
Ranked among companies with meaningful ROE (%) only.
IMRS' s 10-Year ROE (%) Range
Min: -137.84   Max: -2.83
Current: -139.54

-137.84
-2.83
ROA (%) -42.73
IMRS's ROA (%) is ranked lower than
89% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.87 vs. IMRS: -42.73 )
Ranked among companies with meaningful ROA (%) only.
IMRS' s 10-Year ROA (%) Range
Min: -51.9   Max: -1.96
Current: -42.73

-51.9
-1.96
ROC (Joel Greenblatt) (%) -246.70
IMRS's ROC (Joel Greenblatt) (%) is ranked lower than
87% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.74 vs. IMRS: -246.70 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
IMRS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1063.97   Max: -13.72
Current: -246.7

-1063.97
-13.72
Revenue Growth (3Y)(%) -18.70
IMRS's Revenue Growth (3Y)(%) is ranked lower than
87% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. IMRS: -18.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
IMRS' s 10-Year Revenue Growth (3Y)(%) Range
Min: -22.5   Max: 67.6
Current: -18.7

-22.5
67.6
EBITDA Growth (3Y)(%) 2.10
IMRS's EBITDA Growth (3Y)(%) is ranked lower than
63% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. IMRS: 2.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
IMRS' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -65.2   Max: 196.2
Current: 2.1

-65.2
196.2
EPS Growth (3Y)(%) 11.60
IMRS's EPS Growth (3Y)(%) is ranked higher than
58% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.20 vs. IMRS: 11.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
IMRS' s 10-Year EPS Growth (3Y)(%) Range
Min: -59.5   Max: 159.7
Current: 11.6

-59.5
159.7
» IMRS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

IMRS Guru Trades in

Q3 2014

IMRS Guru Trades in Q3 2014

Jim Simons 36,500 sh (New)
» More
Q4 2014

IMRS Guru Trades in Q4 2014

Jim Simons 253,500 sh (+594.52%)
» More
Q1 2015

IMRS Guru Trades in Q1 2015

Jim Simons 332,900 sh (+31.32%)
» More
» Details

Insider Trades

Latest Guru Trades with IMRS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
Forward P/E 17.76
IMRS's Forward P/E is ranked higher than
60% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.28 vs. IMRS: 17.76 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 0.30
IMRS's P/B is ranked lower than
59% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. IMRS: 0.30 )
Ranked among companies with meaningful P/B only.
IMRS' s 10-Year P/B Range
Min: 0.87   Max: 13.64
Current: 0.3

0.87
13.64
P/S 0.09
IMRS's P/S is ranked higher than
74% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.75 vs. IMRS: 0.09 )
Ranked among companies with meaningful P/S only.
IMRS' s 10-Year P/S Range
Min: 0.41   Max: 6.69
Current: 0.09

0.41
6.69
Current Ratio 1.10
IMRS's Current Ratio is ranked lower than
89% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.55 vs. IMRS: 1.10 )
Ranked among companies with meaningful Current Ratio only.
IMRS' s 10-Year Current Ratio Range
Min: 0.64   Max: 8.82
Current: 1.1

0.64
8.82
Quick Ratio 0.81
IMRS's Quick Ratio is ranked lower than
84% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. IMRS: 0.81 )
Ranked among companies with meaningful Quick Ratio only.
IMRS' s 10-Year Quick Ratio Range
Min: 0.57   Max: 8.06
Current: 0.81

0.57
8.06
Days Inventory 72.90
IMRS's Days Inventory is ranked higher than
81% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 121.06 vs. IMRS: 72.90 )
Ranked among companies with meaningful Days Inventory only.
IMRS' s 10-Year Days Inventory Range
Min: 27.68   Max: 176.71
Current: 72.9

27.68
176.71
Days Sales Outstanding 111.23
IMRS's Days Sales Outstanding is ranked lower than
87% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.58 vs. IMRS: 111.23 )
Ranked among companies with meaningful Days Sales Outstanding only.
IMRS' s 10-Year Days Sales Outstanding Range
Min: 19.22   Max: 112.72
Current: 111.23

19.22
112.72

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.36
IMRS's Price/Median PS Value is ranked higher than
94% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.00 vs. IMRS: 0.36 )
Ranked among companies with meaningful Price/Median PS Value only.
IMRS' s 10-Year Price/Median PS Value Range
Min: 0.49   Max: 1.98
Current: 0.36

0.49
1.98
Earnings Yield (Greenblatt) -462.20
IMRS's Earnings Yield (Greenblatt) is ranked lower than
102% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. IMRS: -462.20 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
IMRS' s 10-Year Earnings Yield (Greenblatt) Range
Min: -59.7   Max: 0
Current: -462.2

-59.7
0

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare: » details
Traded in other countries:IM.Canada, 9IM.Germany,
IMRIS Inc was incorporated on May 18, 2005 under the Canada Business Corporations Act. The Company designs, manufactures and markets the VISIUS Surgical TheatreTM, a multifunctional surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. It also provides ancillary products and services and extended maintenance services. Designed to meet each hospital's specific clinical application needs, the VISIUS Surgical Theatre can incorporate MR imaging, CT imaging and x-ray angiography in a number of configurations to provide intraoperative images of diagnostic quality without introducing additional patient transport risk and delivering real-time information to clinicians while preserving optimal surgical access and techniques. The Company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, cerebrovascular and cardiovascular markets.
» More Articles for IMRS

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
IMRIS Inc. and Two Subsidiaries File for Chapter 11 Protection May 26 2015
IMRIS Inc. and Two Subsidiaries File for Chapter 11 Protection May 26 2015
IMRIS Files for Bankruptcy with Buyout Offer From Deerfield May 26 2015
IMRIS Executive Vice Presidents of Global Sales and Global Customer Service Leave the Company May 19 2015
IMRIS Executive Vice Presidents of Global Sales and Global Customer Service Leave the Company May 19 2015
IMRIS Announces Correction of Annual Meeting Record Date to May 15, 2015 May 07 2015
IMRIS Announces Correction of Annual Meeting Record Date to May 15, 2015 May 07 2015
IMRIS Announces Postponement of its Annual Meeting of Shareholders and Release of First Quarter 2015... May 06 2015
IMRIS Announces Postponement of its Annual Meeting of Shareholders and Release of First Quarter 2015... May 06 2015
Nasdaq stocks posting largest volume increases Apr 29 2015
IMRIS to Hold First Quarter 2015 Financial Results Conference Call Apr 29 2015
IMRIS to Hold First Quarter 2015 Financial Results Conference Call Apr 29 2015
IMRIS Announces Receipt of Nasdaq Notice of Bid Price Deficiency Apr 22 2015
IMRIS Announces Receipt of Nasdaq Notice of Bid Price Deficiency Apr 22 2015
Leading neurosurgeons speaking on clinical utility of real-time navigated laser therapy for lesion... Apr 15 2015
Leading neurosurgeons speaking on clinical utility of real-time navigated laser therapy for lesion... Apr 15 2015
IMRIS INC. Financials Apr 07 2015
Health Canada greenlights IMRIS ceiling-mounted intraoperative CT solution Mar 26 2015
Health Canada greenlights IMRIS ceiling-mounted intraoperative CT solution Mar 26 2015
IMRIS Reports Fourth Quarter and Annual 2014 Financial Results Mar 04 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK